Blueprint Medicines Corp
BPMC
Company Profile
Business description
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.
Contact
45 Sidney Street
Cambridge MA 02139
USAT: +1 617 374-7580
E: ir@blueprintmedicines.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2024
Employees
655
Stocks News & Analysis
stocks
2 ASX shares to avoid
An investor favourite is among the two shares trading at a significant premium to our fair value.
stocks
Is this ASX miner a bargain after shares plunge?
We think investors may have overreacted to recent news.
stocks
An undervalued wide moat US share with momentum
Shares of this high-quality company have rallied recently but still look attractive.
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 8,205.50 | 3.10 | -0.04% |
| CAC 40 | 7,517.49 | 81.14 | -1.07% |
| DAX 40 | 18,394.97 | 162.73 | -0.88% |
| Dow JONES (US) | 40,016.01 | 342.08 | -0.85% |
| FTSE 100 | 8,149.11 | 18.26 | -0.22% |
| HKSE | 17,311.05 | 158.31 | -0.91% |
| NASDAQ | 17,631.97 | 365.38 | -2.03% |
| Nikkei 225 | 39,154.85 | 439.54 | -1.11% |
| NZX 50 Index | 12,530.99 | 105.41 | 0.85% |
| S&P 500 | 5,480.91 | 74.83 | -1.35% |
| S&P/ASX 200 | 7,963.70 | 7.40 | -0.09% |
| SSE Composite Index | 2,901.95 | 13.42 | -0.46% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Argosy Minerals Ltd AGY | 0.05 | 0.03 | -39.51% |
| Pilbara Minerals Ltd PLS | 2.89 | 0.00 | 0.00% |
| Sayona Mining Ltd SYA | 0.03 | 0.00 | -3.03% |
| Droneshield Ltd DRO | 1.48 | 0.06 | 3.87% |
| Imugene Ltd IMU | 0.06 | 0.00 | -6.67% |
| Core Lithium Ltd CXO | 0.09 | 0.00 | -4.08% |
| South32 Ltd S32 | 2.96 | 0.02 | -0.67% |
| Zip Co Ltd ZIP | 1.83 | 0.03 | 1.39% |
| Red 5 Ltd RED | 0.42 | 0.03 | 6.41% |
| Worley Ltd WOR | 15.23 | 0.04 | 0.26% |